UNSPSC 41202010: Chlamydia serological reagents

In this classification, Chlamydia serological reagents are devices used in test to identify specific Chlamydia antibodies in serum. US FDA regulates Chlamydia serological reagents under 21 CFR 866.3120 and under FDA product code GPW.

UNSPSC 41202010 Chlamydia serological reagents is a Commodity code that encompasses HIV and Syphilis testing kits, screening assays, reagents, and related diagnostic supplies procured by state and local public health departments, criminal justice agencies, and educational institutions. Recent state and local solicitations show substantial divergence from the code's nominal scope—the opportunities listed tag HIV and Syphilis reagents under this Chlamydia code, reflecting how state and local procurement systems sometimes apply codes that do not match the work being transacted. The actual buying activity consists of rapid diagnostic test kits (Abbott Determine HIV 1/2 Ag/Ab Combo kits), fully automated combination screening instruments and reagents capable of simultaneous Hepatitis B, Hepatitis C, HIV-1/HIV-2, and Syphilis detection, laboratory consumables and calibrator kits for analyzer systems, and maintenance and technical support services. Issuing bodies include state departments of public health (Illinois Department of Public Health), county community supervision and corrections departments (Collin County), city health programs (City of Austin), state corrections agencies (Texas Department of Criminal Justice), and higher education institutions (University of Houston).

Geographic concentration is notable in Texas and Illinois, with recent activity spanning Collin County (Plano and McKinney), Austin, Carbondale and Jackson County (Illinois), and Houston. Representative recent opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated contract value $600,000 over two years with optional renewals through five years total), the City of Austin's IFB 9100AAM1023 for rapid HIV test kits to support the Austin Public Health Program (due July 17, 2026), the Illinois Department of Public Health's IFB for Hepatitis/HIV/Syphilis 4th generation combination screening assays and instrumentation (due March 16, 2026, five-year term with up to five additional renewal years), and the Texas Department of Criminal Justice's RFP 696-IG-26-P034 for forensic analysis and expert witness testimony services including serology testing (due May 13, 2026, one-year base period with four optional one-year renewals). Illinois has conducted multiple emergency sole-source procurements with Abbott Laboratories for HIV and Syphilis reagents at $38,079.50 per contract.